Topline data were announced from a phase 3b trial evaluating the concomitant use of ixekizumab and tirzepatide in active PsA and obesity.
The TOGETHER-PsA study shows that combining ixekizumab with tirzepatide leads to significantly better psoriatic arthritis ...
Daily Voice on MSN
Here's Timing For New Winter Storm Where, When Snow, Sleet, Strong Winds Will Hit: Update
A new winter storm is on track to bring widespread snow, a wintry mix, and gusty winds to the Northeast, with hazardous ...
Strong execution delivers 2025 financial performance in line with guidance, with all business units contributing to growth.
UCB Canada Inc. is pleased to announce Health Canada has granted a Notice of Compliance (NOC) for PrBIMZELX® (bimekizumab injection) indicated for the treatment of adult patients with moderate to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback